Celsion Corporation
CLSN
#10430
Rank
A$19.77 M
Marketcap
A$2.79
Share price
0.00%
Change (1 day)
-19.18%
Change (1 year)

Earnings for Celsion Corporation (CLSN)

Earnings in 2022 (TTM): -A$29.71 Million

According to Celsion Corporation 's latest financial reports the company's current earnings are A$0.5 Million. In 2021 the company made an earning of -A$30.68 Million, an increase over its 2020 earnings that were of -A$31.32 Million.

Earnings history for Celsion Corporation from 2001 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)-A$29.71 Million-3.17%
2021-A$30.68 Million-2.06%
2020-A$31.32 Million27.57%
2019-A$24.56 Million-19.99%
2018-A$30.69 Million6.3%
2017-A$28.87 Million-4.78%
2016-A$30.32 Million1.07%
2015-A$30 Million-12.68%
2014-A$34.35 Million229.44%
2013-A$10.43 Million-71.68%
2012-A$36.82 Million11.15%
2011-A$33.13 Million14.54%
2010-A$28.92 Million27.92%
2009-A$22.61 Million29.06%
2008-A$17.52 Million-4.11%
2007-A$18.27 Million34.55%
2006-A$13.58 Million2.95%
2005-A$13.19 Million-36.44%
2004-A$20.75 Million1.85%
2003-A$20.38 Million41.77%
2002-A$14.37 Million36.14%
2001-A$10.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ziopharm Oncology
ZIOP
-A$0.13 Billion 302.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$87.95 Million 179.34%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-A$89.23 Million 183.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.42 B-4,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA